Journal of The Academy of Clinical Microbiologists

Register      Login

VOLUME 17 , ISSUE 1 ( January-June, 2015 ) > List of Articles

Original Article

Determination of Vancomycin, Teicoplanin and Linezolid resistance among Staphylococcal isolates from a tertiary care hospital

Shashikala Shivaprakasha

Keywords : CoNS glycopeptides resistance, CoNS Linezolid, Teicoplanin resistance, CoNS Vancomycin, S. epidermidis, S. aureus, S. haemolyticus

Citation Information : Shivaprakasha S. Determination of Vancomycin, Teicoplanin and Linezolid resistance among Staphylococcal isolates from a tertiary care hospital. 2015; 17 (1):3-6.

DOI: 10.4103/0972-1282.158766

License: CC BY-NC-SA 4.0

Published Online: 15-07-2024

Copyright Statement:  Copyright © 2015; Wolters Kluwer India Pvt. Ltd.


Abstract

Background and Objectives: Increasing reports of Vancomycin creep have been observed in both Methicillin sensitive and Methicillin resistant staphylococcal isolates. The objective of this study was to determine the sensitivity pattern among clinical isolates of Methicillin sensitive and Methicillin resistant Staphylococcus aureus (MRSA), S. epidermidis, S. haemolyticus, to Vancomycin, Teicoplanin and Linezolid. Materials and Methods: A total of 82 S. aureus, 34 S. epidermidis and 26 S. haemolyticus isolated during Jan 2011 to Dec 2011 were included in the study. None of the S. aureus isolates were resistant to Vancomycin and Linezolid. Only one MRSA isolate was resistant to Teicoplanin. Vancomycin resistant strains among Methicillin resistant S. epidermidis was one (4.3%) and among S. haemolyticus was two (8.3%) respectively. Teicoplanin resistant strains among Methicillin resistant S. epidermidis was six (26.1%) and among S. haemolyticus was two (8.3%). Linezolid resistant strains among Methicillin resistant S. epidermidis was two (8.7%) and among S. haemolyticus was one (4.2%). Conclusion: Emergence of Vancomycin, Teicoplanin and Linezolid resistance among Methicillin resistant coagulase negative staphylococci (CoNS) is alarming limiting the therapeutic options.


PDF Share
  1. Dhand A, Sakoulas G. Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): Implications for therapy. F1000 Med Rep 2012;4:4.
  2. Menezes GA, Harish BN, Sujatha S, Vinothini K, Parija SC. Emergence of vancomycin-intermediate Staphylococcus species in southern India. J Med Microbiol 2008;57:911-2.
  3. Dhawan B, Gadepalli R, Rao C, Kapil A, Sreenivas V. Decreased susceptibility to vancomycin in meticillin-resistant Staphylococcus aureus: A 5 year study in an Indian tertiary hospital. J Med Microbiol 2010;59:375-6.
  4. Ramana BV, Chaudhury A. Rising incidence of high MIC for vancomycin among Staphylococcus aureus strains at a Tertiary Care Hospital in South India. J Pharm Bioallied Sci 2012;4:173.
  5. Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a Tertiary Care Hospital from northern part of India. BMC Infect Dis 2006;6:156.
  6. Bhakta A, Bhattacharyya M, Todi S. A creep in the vancomycin minimum inhibitory concentration for Staphylococcus aureus in a Tertiary Care Hospital in India. Crit Care 2011;15:P232.
  7. Reddy CM, Thati V, Shivannavar CT, Gaddad S. Vancomycin resistance among methicillin resistant Staphylococcus sureus isolates in Rayalseema region Andhra Pradesh, South India. World J Sci Technol 2012;2:06-08.
  8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty First Informational Supplement. M100-S17. Wayne, PA: CLSI; 2011.
  9. Sujatha S, Praharaj I. Glycopeptide resistance in gram-positive cocci: A review. Interdiscip Perspect Infect Dis 2012;2012:781679.
  10. Song JH, Hiramatsu K, Suh JY, Ko KS, Ito T, Kapi M, et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2004;48:4926-8.
  11. Kalawat U, Sharma KK, Reddy S. Linezolid-resistant Staphylococcus spp. at a Tertiary Care Hospital of Andhra Pradesh. Indian J Med Microbiol 2011;29:314-5.
  12. Peer MA, Nasir RA, Kakru DK, Fomda BA, Bashir G, Sheikh IA. Sepsis due to linezolid resistant Staphylococcus cohnii and Staphylococcus kloosii: First reports of linezolid resistance in coagulase negative staphylococci from India. Indian J Med Microbiol 2011;29:60-2.
  13. Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, et al. Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative staphylococci isolates from paediatric blood cultures. Rev Esp Quimioter 2012;25:25-30.
  14. Ahlstrand E, Svensson K, Persson L, Tidefelt U, Söderquist B. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades. Eur J Clin Microbiol Infect Dis 2011;30:1349-54.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.